A detailed history of Farallon Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 4,000 shares of RARE stock, worth $175,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,000
Previous 99,000 95.96%
Holding current value
$175,000
Previous $4.07 Million 94.54%
% of portfolio
0.0%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.21 - $59.36 $3.82 Million - $5.64 Million
-95,000 Reduced 95.96%
4,000 $222,000
Q1 2024

May 15, 2024

BUY
$43.02 - $53.69 $4.26 Million - $5.32 Million
99,000 New
99,000 $4.62 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.